leadf
logo-loader
viewLexaGene Holdings Inc.

LexaGene moves forward with its faster, easier pathogen detection

LexaGene Holdings (CVE:LXG) (OTCQB:LXXGF) Co-founder and CEO Dr. Jack Regan joined Katie Lewis from the Vancouver studio of Proactive Investors to discuss the firm's recent announcement.

LexaGene's key feature is the open access nature of the instrument that allows end users to customize the instrument to target any pathogen of interest. The process is as simple as collecting a sample, loading it into the instrument using a preparation cartridge and pressing “go.” The instrument is able to process multiple samples at a time, returning results within around one hour.forward with its faster, easier pathogen detection

Quick facts: LexaGene Holdings Inc.

Price: 0.76 CAD

TSX-V:LXG
Market: TSX-V
Market Cap: $86.42 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

LexaGene hires two salespeople to tackle diagnostic and vet market with new...

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company has made two key sales hires as they look to begin to roll out their genetic analyzers for rapid pathogen detection called MiQLab. Regan says they are hiring in the...

on 14/7/20

2 min read